Flood Law Group, LLP is sponsoring the new website, PradaxaInjury.com, designed to educate people about the potential side effects associated with the anticoagulant medication, Pradaxa® (dabigatran etexilate).
According to Flood Law Group, LLP, people who are treated with Pradaxa® and who suffer severe internal bleeding, heart attack and/or other serious complications may be entitled to pursue damages such as medical bills, pain and suffering.
Pradaxa® is prescribed to patients with non-valvular atrial fibrillation (AF), a heart rhythm problem. Its purpose is to reduce the risk of stroke in these patients.
It is no secret that anticoagulant medications increase the risk of internal bleeding in some patients. But, there is a possibility that Pradaxa® may put patients at a greater risk for serious bleeding events than what is expected.
Because of this, the U.S. Food and Drug Administration (FDA) issued a safety communication on Dec. 7, 2011 to notify the public that it is evaluating post-marketing reports of severe bleeding events in people taking Pradaxa®.
“FDA is working to determine whether the reports of bleeding in patients taking Pradaxa® are occurring more commonly than would be expected, based on observations in the large clinical trial that supported the approval of Pradaxa®,” the FDA said in the safety communication.
People that are treated with Pradaxa® should be aware of the signs of internal bleeding, including unexplained bleeding from the gums, frequent nosebleeds, coughing up blood, vomiting what looks like coffee grounds, dark-colored stools and pink or brown urine.
Pradaxa® has also been linked to an increase in the risk of heart complications, including severe heart disease symptoms and heart attack.
For more information, visit PradaxaInjury.com or contact Flood Law Group, LLP.